Literature DB >> 6605279

Plasma steroid levels and clinical effects after topical application of betamethasone.

S Baba, H Mishima, M Okimoto, Y Miyachi.   

Abstract

A study was made of 41 patients (45 eyes) with post-operative irritative conditions to evaluate the clinical efficacy of topical betamethasone (BM) at various concentrations. The results obtained were as follows. First, serum concentrations of BM after treatment with 0.01% and 0.05% BM solution were much lower than those found after a 0.1% solution had been applied. However, no reduction in the serum cortisol was observed in the former. Second, the clinical evaluation was made in patients after cataract extraction. Marked and moderate improvement of post-operative inflammatory changes was observed in 90% of the patients treated with 0.05% and 0.1% solution and in only 30% of those treated with 0.01% solution. This study clearly shows the efficiency of 0.05% solution of BM with minimal suppressive effects on adrenal function.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6605279     DOI: 10.1007/bf02308076

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  12 in total

1.  [Not Available].

Authors:  J FRANCOIS
Journal:  Ann Ocul (Paris)       Date:  1954-09

2.  Acute glaucoma during cortisone therapy.

Authors:  J J STERN
Journal:  Am J Ophthalmol       Date:  1953-03       Impact factor: 5.258

3.  Topical corticosteroid therapy and pituitary-adrenal function.

Authors:  T Krupin; A I Mandell; S M Podos; B Becker
Journal:  Arch Ophthalmol       Date:  1976-06

4.  A radioimmunoassay for cortisol in plasma and urine.

Authors:  H J Ruder; R L Guy; M B Lipsett
Journal:  J Clin Endocrinol Metab       Date:  1972-08       Impact factor: 5.958

5.  [Statistical evaluation of the effects of betamethasone ophthalmic solution (Rinderon) on the anterior uveitis using the sequential method by Wald].

Authors:  M Nagata
Journal:  Nihon Ganka Kiyo       Date:  1970-02

6.  Topically applied steroids in corneal disease. I. The role of inflammation in stromal absorption of dexamethasone.

Authors:  W V Cox; A Kupferman; H M Leibowitz
Journal:  Arch Ophthalmol       Date:  1972-09

7.  Systemic absorption of topical steroids.

Authors:  P G Burch; C J Migeon
Journal:  Arch Ophthalmol       Date:  1968-02

8.  Blood levels of synthetic glucocorticoids after administration by various routes.

Authors:  Y Miyachi; H Yotsumoto; T Kano; A Mizuchi; T Muto; K Yanagibashi
Journal:  J Endocrinol       Date:  1979-07       Impact factor: 4.286

9.  Ocular penetration studies. I. Topical administration of dexamethasone.

Authors:  C Short; R H Keates; E F Donovan; M Wyman; P W Murdick
Journal:  Arch Ophthalmol       Date:  1966-05

10.  Ocular penetration studies. II. Topical administration of prednisolone.

Authors:  P W Murdick; R H Keates; E F Donovan; M Wyman; C Short
Journal:  Arch Ophthalmol       Date:  1966-10
View more
  2 in total

Review 1.  Locally administered ocular corticosteroids: benefits and risks.

Authors:  Charles N J McGhee; Simon Dean; Helen Danesh-Meyer
Journal:  Drug Saf       Date:  2002       Impact factor: 5.606

2.  Intraocular administration of tetramethylpyrazine hydrochloride to rats: a direct delivery pathway for brain targeting?

Authors:  Dan Mao; Fang Li; Qun Ma; Manman Dai; Huimin Zhang; Luyu Bai; Ning He
Journal:  Drug Deliv       Date:  2019-12       Impact factor: 6.419

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.